Early Rescue of Lymphatic Function Limits Atherosclerosis Progression in Ldlr-/ Mice

被引：0
|
作者：
Milasan, Andreea
Smaani, Ali
Martel, Catherine
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A104
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Passive immunization with anti-LDL(-) antibodies inhibit atherosclerosis in LDLR-/- mice
    Grosso, D. M.
    Bonito, A.
    Krieger, M. H.
    Abdalla, D. S. P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 197 - 197
  • [42] Dietary phosphatidylcholine supplementation reduces atherosclerosis in Ldlr-/- male mice2
    Aldana-Hernandez, Paulina
    Azarcoya-Barrera, Jessy
    Veen, Jelske N. van der
    Leonard, Kelly-Ann
    Zhao, Yuan-Yuan
    Nelson, Randal
    Goruk, Susan
    Field, Catherine J.
    Curtis, Jonathan M.
    Richard, Caroline
    Jacobs, Rene L.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2021, 92
  • [43] A Diet Induced Atherosclerosis in LDLR-/- Mice Is Associated With Altered HDL Proteome Dynamics
    Kasumov, Takhar
    Li, Ling
    Willard, Belinda
    Hazen, Stanley L.
    Smith, Jonathan D.
    McCullough, Arthur
    CIRCULATION, 2013, 128 (22)
  • [44] Improvements of Atherosclerosis and Hepatic Oxidative Stress are Independent of Exercise Intensity in LDLr-/- Mice
    Teodoro, Bruno Gonzaga
    Natali, Antonio Jose
    Toledo Fernandes, Silvio Anderson
    da Silva, Luciano Acordi
    de Pinho, Ricardo Aurino
    Pinto da Matta, Sergio Luis
    Gouveia Peluzio, Maria do Carmo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (10) : 904 - 911
  • [45] Myeloid interferon-γ receptor deficiency does not affect atherosclerosis in LDLR-/- mice
    Boshuizen, Marieke C. S.
    Neele, Annette E.
    Gijbels, Marion J. J.
    van der Velden, Saskia
    Hoeksema, Marten A.
    Forman, Ruth A.
    Muller, Werner
    Van den Bossche, Jan
    de Winther, Menno P. J.
    ATHEROSCLEROSIS, 2016, 246 : 325 - 333
  • [46] Passive immunization with IK-17, a human oxidation-specific antibody, reduces progression of atherosclerosis in LDLR-/- mice
    Merki, Esther
    Shaw, Peter X.
    Witztum, Joseph L.
    Tsimikas, Sotirios
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E97 - E97
  • [47] Age-related and atherosclerosis-related erythropathy in ApoE/LDLR-/- mice
    Dybas, Jakub
    Bulat, Katarzyna
    Blat, Aneta
    Mohaissen, Tasnim
    Wajda, Aleksandra
    Mardyla, Mateusz
    Kaczmarska, Magdalena
    Franczyk-Zarow, Magdalena
    Malek, Kamilla
    Chlopicki, Stefan
    Marzec, Katarzyna M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (12):
  • [48] Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr-/- mice
    van Leuven, Sander I.
    Mendez-Fernandez, Yanice V.
    Wilhelm, Ashley J.
    Wade, Nekeithia S.
    Gabriel, Curtis L.
    Kastelein, John J.
    Stroes, Erik S.
    Tak, Paul P.
    Major, Amy S.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 408 - 414
  • [49] The PPARδ agonist GW0742X reduces atherosclerosis in LDLR-/- mice
    Graham, TL
    Mookherjee, C
    Suckling, KE
    Palmer, CNA
    Patel, L
    ATHEROSCLEROSIS, 2005, 181 (01) : 29 - 37
  • [50] Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia
    Mueller, Marc A.
    Beutner, Frank
    Teupser, Daniel
    Ceglarek, Uta
    Thiery, Joachim
    ATHEROSCLEROSIS, 2008, 198 (01) : 39 - 48
12345